Dixon; Julie Patent Filings

Patent	Date
Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases Grant 8,431,695 - O'Connor , et al. April 30, 2	2013-04-30
Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase Grant 8,338,594 - Magnuson , et al. December 25, 2	2012-12-25
Substituted 4-amino-pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis App 20120165314 - Dixon; Julie ; et al.	2012-06-28
Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis Grant 8,133,995 - Dixon , et al. March 13, 2	2012-03-13
Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors for the Treatment of Cancer and Other Hyperproliferative Diseases App 20110294776 - O'Connor; Stephen ; et al.	2011-12-01
Pyrrolotriazine Derivatives Useful For Treating Cancer Through Inhibition Of Aurora Kinase App 20110021518 - Magnuson; Steven ; et al.	2011-01-27
Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis App 20100063038 - Dixon; Julie ; et al.	2010-03-11
Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated With Angiogenesis App 20090281079 - Dixon; Julie ; et al.	2009-11-12

Patent

Date

Pyrrolo[2,1-f][1,2,4]triazin-4-ylamines IGF-1R kinase inhibitors for the treatment of cancer and other hyperproliferative diseases
Grant 8,431,695 - O'Connor , et al. April 30, 2

2013-04-30

Pyrrolotriazine derivatives useful for treating cancer through inhibition of aurora kinase
Grant 8,338,594 - Magnuson , et al. December 25, 2

2012-12-25

Substituted 4-amino-pyrrolotriazine Derivatives Useful For Treating Hyper-proliferative Disorders And Diseases Associated With Angiogenesis
App 20120165314 - Dixon; Julie ; et al.

2012-06-28

Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
Grant 8,133,995 - Dixon , et al. March 13, 2

2012-03-13

Pyrrolo[2,1-F] [1,2,4] Triazin-4-Ylamines IGF-1R Kinase Inhibitors for the Treatment of Cancer and Other Hyperproliferative Diseases
App 20110294776 - O'Connor; Stephen ; et al.

2011-12-01

Pyrrolotriazine Derivatives Useful For Treating Cancer Through Inhibition Of Aurora Kinase
App 20110021518 - Magnuson; Steven ; et al.

2011-01-27

Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated with Angiogenesis
App 20100063038 - Dixon; Julie ; et al.

2010-03-11

Substituted 4-Amino-Pyrrolotriazine Derivatives Useful for Treating Hyper-Proliferative Disorders and Diseases Associated With Angiogenesis
App 20090281079 - Dixon; Julie ; et al.

2009-11-12

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

Dixon; Julie

Patent Applications and Registrations